1-3 of 3
Pramod Srivastava
Close
Sort by
Journal Articles

Preliminary Results from a Phase 2 Trial of AG-858, an Autologous Heat Shock Protein-Peptide Vaccine, in Combination with Imatinib in Patients with Chronic Phase Chronic Myeloid Leukemia (CML) Resistant to Prior Imatinib Monotherapy.

David Marin, MD, Michael Mauro, MD, John Goldman, MD, Brian Druker, MD, Steven Devine, MD, Richard E. Clark, MD, Ronald Paquette, MD, Asad Bashey, MD, Martin S. Tallman, MD, April Dovholuk, Axel Hoos, MD, PhD, Pramod Srivastava, PhD
Journal: Blood
Blood (2005) 106 (11): 1094.
https://doi.org/10.1182/blood.V106.11.1094.1094
Published: 2005
Journal Articles

Disease-associated dendritic cells respond to disease-specific antigens through the common heat shock protein receptor

Justin Stebbing, Brian Gazzard, Simon Portsmouth, Frances Gotch, Louise Kim, Mark Bower, Sundhiya Mandalia, Robert Binder, Pramod Srivastava, Steve Patterson
Journal: Blood
Blood (2003) 102 (5): 1806–1814.
https://doi.org/10.1182/blood-2003-03-0891
Published: 2003
Journal Articles

The heat-shock protein receptor CD91 is up-regulated in monocytes of HIV-1–infected “true” long-term nonprogressors

Justin Stebbing, Brian Gazzard, Louise Kim, Simon Portsmouth, Adrian Wildfire, Ian Teo, Mark Nelson, Mark Bower, Frances Gotch, Sunil Shaunak, Pramod Srivastava, Steve Patterson
Journal: Blood
Blood (2003) 101 (10): 4000–4004.
https://doi.org/10.1182/blood-2002-11-3353
Published: 2003